PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Practical Framework for Managing Anticoagulant-Associated Bleeding

apixabanrivaroxabandabigatranedoxabanDOACvitamin K antagonistwarfarinandexanet alfaidarucizumabprothrombin complex concentrateatrial fibrillationPCIbleeding managementreversal agentsanticoagulationnarrative reviewBARCHAS-BLED Anticoagulation / Hematology

Background Information

Bleeding risks complicate anticoagulant therapy management in cardiovascular patients.

Managing bleeding in patients on anticoagulant therapy is crucial due to its high association with morbidity and mortality. The article provides patient-centered flowcharts for acute bleeding management and safe anticoagulation resumption. Highlights the need for individualized anticoagulant regimens and access to reversal agents; emphasizes risk versus benefit balance. Balancing thrombotic and bleeding risks is essential in anticoagulant therapy management.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Galli M, Simeone B, Ten Berg J, Capodanno D, Valgimigli M, Sciarretta S, Greco E, Kastrati A, Montalescot G, Gibson CM, Gorog DA, Mehran R, Angiolillo DJ

Citation: Galli M, Simeone B, Ten Berg J, et al. Managing bleeds on anticoagulant therapy: a practical guide for clinicians. European heart journal. Acute cardiovascular care. 2026;15(7):557-572. doi:10.1093/ehjacc/zuag035

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.